|
|
|
|
|
|
In the United States mortality from pneumococcal pneumonia is 1 in 20, in cases where the disease progresses to blood poisoning, bacteremia, 2 of 10 die and where the disease affects the brain, meningitis, 3 of 10 die. History of pneumonia: Before the advent of antibiotics, pneumonia was often fatal. When penicillin was discovered in the 20th century, it was the first causal therapy. Most community-acquired strains of S. pneumoniae are still penicillin-sensitive. Notable pneumonia sufferers Many famous people throughout the years have succumbed to pneumonia and its complications. As it is a common cause of death of death in the chronically ill, this is not always reported in the press. A well known and tragically sudden death due to pneumonia was that of Muppets creator Jim Henson in the early 1990s. 19th Century Sharpshooter Calamity Jane. Christmas Seals was started in 1904 in Denmark as a way to raise money for tuberculosis programs. It expanded to the United States and Canada in 1907-08 to help the National Tuberculosis Association, later called the American Lung Association. Mycobacterium bovis is a type of bacterium that causes tuberculosis in cattle. It is related to the bacteria which causes tuberculosis in humans and leprosy. M. bovis can also jump the species barrier and cause tuberculosis in humans. Mycobacterium bovis (the bacterium responsible for bovine TB) in particular has been estimated to be responsible, for the period of the first half of the 20th century, for more losses among farm animals than all other infectious diseases combined. Infection occurs if the bacterium is ingested. Click on following items to see more information: Anaerobic bacteria, Antibiotics, Antibiotic resistance, Bactericidal, Bacillus, Bacillus, Bacteria, Bacteriological, Phage, Beta lactamase, Brevibacteria, Candida pseudotropicalis, Cell suspensions, Clostridia, Denitrifying, Escherichia coli, Escherichia coli, Escherichia coli, Escherichia coli, Escherichia coli, Enterobacteriacea, Fermentations, Yeasts, Gram positive, Halophilic bacterium, Listeriosis, Bacteriological, Microbiological, Bacteria, Nitrifying, Prokaryotes, Pseudomonas aeruginosa, Rhizobacter, S. cerevisiae, S. cerevisiae, Salmonella typhimurium, Waste treatment, Staphylococcus aureus, Streptococcal, Streptococcal, Vancomycin, Yeasts The Hydrogenophilaceae are a small family of Proteobacteria, with two genera. Hydrogenophilus are thermophilic, growing around 50°C, and obtain their energy from oxidizing hydrogen. The genus Thiobacillus, redefined to include only those species included among the beta proteobacteria, is also included here. Other members of Thiobacillus were transfred to Acidithiobacillus, Halothiobacillus and Thermithiobacillus, now placed in other families. The Enterobacteriaceae are a large family of bacteria, including many of the more familiar pathogens, such as Salmonella and Escherichia coli. Genetic studies place them among the Proteobacteria, and they are given their own order (Enterobacteriales), though this is sometimes taken to include some related environmental samples. Not all contaminants are readily treated through the use of bioremediation; for example, heavy metals such as cadmium and lead are not readily absorbed or captured by organisms. The integration of metals such as mercury into the food chain may make things worse as organisms bioaccumulate these metals. However, there are a number of advantages to bioremediation, which may be employed in areas which cannot be reached easily without excavation. For example, hydrocarbon spills (or more specific: gasoline) may contaminate groundwater well below the surface of the ground; injecting the right organisms, in conjunction with oxygen-forming compounds, may significantly reduce concentrations after a period of time. This is much less expensive than excavation followed by burial elsewhere or incineration, and reduces or eliminates the need for pumping and treatment, which is a common practice at sites where hydrocarbons have contaminated groundwater.
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||
